# Ianalumab reduces Sjögren disease activity

Source: [Medical research : nature.com subject feeds](https://www.nature.com/articles/s41584-026-01466-3) · 2026-11-10 · Medicine
Page: https://themorning.science/story/ianalumab-reduces-sjogren-disease-activity-ef46ca202c6507a7
Kind: research · Impact: medium

## In brief

- Headline reports that ianalumab reduces Sjögren disease activity.
- The item comes from a Nature subject feed dated 2026-11-10 and has no summary.

## Why it matters

Sjögren disease is an autoimmune condition with limited targeted treatments, so a reported reduction in disease activity with ianalumab is relevant to rheumatology research. The source provides no further detail on methods or results.

## Coverage

- [Ianalumab reduces Sjögren disease activity](https://www.nature.com/articles/s41584-026-01466-3) — Medical research : nature.com subject feeds, 2026-11-10

Tags: sjogren, ianalumab, autoimmune, rheumatology, disease activity

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science